
Dr Panagiotis Kaloyannidi
Specialist Clinical Hematology
Burjeel Medical City
Abu Dhabi, UAE
At the 1st Emirates Hematology Forum, 31 October 2026
- Speaker · 09:50–10:05Bispecific T-Cell Engager Therapies: The Role of BiTEs in Hematologic MalignanciesSession: Rewriting the Myeloma Playbook
- Panelist · 10:05–10:35Panel Discussion: Optimal Duration of Maintenance Therapy in Frontline Multiple Myeloma: When, If Ever, Should We Stop? · Sequencing of Therapies in Second Line: CAR-T then BiTEs or BiTEs then CAR-TSession: Rewriting the Myeloma Playbook
To correct or remove this profile, write to secretariat@eora.ae.
